1. Brainware University Digital Repository
  2. Serial Abstracting Service
  3. Journal & Magazine Article Abstracts
  4. Indian Journal of Medical Research
  5. Vol. 163, No.4, 2026
Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5627
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMonika Gupta-
dc.date.accessioned2026-07-08T06:54:36Z-
dc.date.available2026-07-08T06:54:36Z-
dc.date.issued2026-07-08-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5627-
dc.descriptionVol. 163, No. 4, p 427en_US
dc.language.isoenen_US
dc.subjectIncretin therapyen_US
dc.subjectMASHen_US
dc.subjectMetabolic Sydromeen_US
dc.subjectType 2 diabetesen_US
dc.titleevolution of incretin-based therapies : From CLP-1 monotherapy to dual and triple agonists : a new era in metabolic therapyen_US
dc.typeOtheren_US
Appears in Collections:Vol. 163, No.4, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol. 163, No. 4, p 427157.48 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.